Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B. Mussini C, et al. Among authors: pezzotti p. J Infect Dis. 2000 May;181(5):1635-42. doi: 10.1086/315471. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823763 Clinical Trial.
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.
Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein RS, Des Jarlais DC, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan JE. Hershow RC, et al. Among authors: pezzotti p. J Infect Dis. 1996 Aug;174(2):309-17. doi: 10.1093/infdis/174.2.309. J Infect Dis. 1996. PMID: 8699060
Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users.
Pozio E, Rezza G, Boschini A, Pezzotti P, Tamburrini A, Rossi P, Di Fine M, Smacchia C, Schiesari A, Gattei E, Zucconi R, Ballarini P. Pozio E, et al. Among authors: pezzotti p. J Infect Dis. 1997 Oct;176(4):969-75. doi: 10.1086/516498. J Infect Dis. 1997. PMID: 9333155
Changing disease patterns in focal brain lesion-causing disorders in AIDS.
Ammassari A, Scoppettuolo G, Murri R, Pezzotti P, Cingolani A, Del Borgo C, De Luca A, Antinori A, Ortona L. Ammassari A, et al. Among authors: pezzotti p. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1;18(4):365-71. doi: 10.1097/00042560-199808010-00008. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9704942
Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group.
Dorrucci M, Rezza G, Andreoni M, Pezzotti P, Nicastri E, Ventura L, Zignani M, Alliegro MB, Tarantini G, Salassa B, Colangeli V, Mazzarello G, Ursitti MA, Barbanera M, Pristerà R, Castelli F, Ortona L. Dorrucci M, et al. Among authors: pezzotti p. Eur J Epidemiol. 1999 Apr;15(4):317-22. doi: 10.1023/a:1007503018729. Eur J Epidemiol. 1999. PMID: 10414371
350 results